# T. Rowe Price Capital Appreciation (PRWCX)

> Source: Nexqual · https://nexqual.com/PRWCX · data as of 2026-10-24 00:03 UTC · cite as "Nexqual, T. Rowe Price Capital Appreciation (PRWCX), nexqual.com/PRWCX" · informational, not investment advice.

**Price:** USD 38.98 (-0.33% on the day) · last close of Oct 23, 2026; US market closed, not a live price. Prev close 39.11 · day 38.98–38.98 · 52w 33.93–39.31 · market cap null · NAS

## Key facts
- Total return with dividends: 1Y +8.9% vs S&P 500 +13.4%; 5Y +46.0% vs S&P 500 +76.9%.

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-24) | 5Y (from 2021-10-25) |
|---|---|---|
| Total return | +8.9% | +46.0% |
| S&P 500 (SPY) | +13.4% | +76.9% |
| Per year | +9.0% | +7.9% |
| Volatility (annualized) | 8.0% | 10.8% |
| Max drawdown | -6.3% (Jan 2026→Mar 2026) | -16.9% (Dec 2021→Oct 2022) |

## Peers
PRHSX (T. Rowe Price Health Sciences F) USD 97.06 +0.00% · PRFDX (T. Rowe Price Equity Income Fd) USD 45.64 +0.00% · TRMCX (T. Rowe Price Mid-Cap Value Fun) USD 37.81 -0.00% · PRNEX (T. Rowe Price New Era Fund) USD 48.11 -0.00% · PRNHX (T. Rowe Price New Horizons Fund) USD 54.9 -0.00%

## More
Full page: https://nexqual.com/PRWCX · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt